13.7% | Eli Lilly and Company, accessed April 23, 2025, How to Use, Dosing & Side Effects | Mounjaro (tirzepatide) - Eli Lilly, accessed April 23, 2025, Mounjaro (tirzepatide) Injection: The First and Only GIP and GLP-1 Receptor Agonist Approved for Type 2 Diabetes | Eli Lilly and Company, accessed April 23, 2025, Lilly's SURMOUNT-1 results published in The New England Journal of Medicine show tirzepatide achieved between 16.0% and 22.5% weight loss in adults with obesity or overweight, accessed April 23, 2025, Why you're not losing weight on Zepbound
Which Semaglutide Is Best for Your Situation
To get started ,you need to fill in their quiz
Wegovy, which has the active ingredient semaglutide, is a brand-name injectable medication approved by the Food and Drug Administration (FDA) in 2021
Hold the pen up to the light and check that the solution is clear and colorless